Toll Free: 1-888-928-9744

Asia-Pacific Spinal Muscular Atrophy Medicine Industry 2018 Market Research Report

Published: Feb, 2018 | Pages: 117 | Publisher: QYResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

In this report, the Asia-Pacific Spinal Muscular Atrophy Medicine market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Spinal Muscular Atrophy Medicine for these regions, from 2013 to 2025 (forecast), including
    China
    Japan
    South Korea
    Taiwan
    India
    Southeast Asia
    Australia

Asia-Pacific Spinal Muscular Atrophy Medicine market competition by top manufacturers/players, with Spinal Muscular Atrophy Medicine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Astellas Pharma Inc.
    AveXis, Inc.
    Bioblast Pharma Ltd.
    Cytokinetics, Inc. 24
    F. Hoffmann-La Roche Ltd.
    Genethon
    Genzyme Corporation
    GMP-Orphan SAS
    Ionis Pharmaceuticals, Inc.
    Longevity Biotech, Inc
    Neurodyn Inc.
    Neurotune AG
    Novartis AG
    Sarepta Therapeutics, Inc.
    Voyager Therapeutics, Inc.
    Vybion, Inc.
    WAVE Life Sciences Ltd.

On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
    LMI-070
    ND-602
    NT-1654
    Nusinersen
    NXD-30001
    Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospital
    Clinic
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 Table of Contents

Asia-Pacific Spinal Muscular Atrophy Medicine Market Report 2018
1 Spinal Muscular Atrophy Medicine Overview
    1.1 Product Overview and Scope of Spinal Muscular Atrophy Medicine
    1.2 Classification of Spinal Muscular Atrophy Medicine by Product Category
        1.2.1 Asia-Pacific Spinal Muscular Atrophy Medicine Market Size (Sales) Comparison by Types (2013-2025)
        1.2.2 Asia-Pacific Spinal Muscular Atrophy Medicine Market Size (Sales) Market Share by Type (Product Category) in 2017
        1.2.3 LMI-070
        1.2.4 ND-602
        1.2.5 NT-1654
        1.2.6 Nusinersen
        1.2.7 NXD-30001
        1.2.8 Others
    1.3 Asia-Pacific Spinal Muscular Atrophy Medicine Market by Application/End Users
        1.3.1 Asia-Pacific Spinal Muscular Atrophy Medicine Sales (Volume) and Market Share Comparison by Applications (2013-2025)
        1.3.2 Hospital
        1.3.3 Clinic
        1.3.4 Others
    1.4 Asia-Pacific Spinal Muscular Atrophy Medicine Market by Region
        1.4.1 Asia-Pacific Spinal Muscular Atrophy Medicine Market Size (Value) Comparison by Region (2013-2025)
        1.4.2 China Status and Prospect (2013-2025)
        1.4.3 Japan Status and Prospect (2013-2025)
        1.4.4 South Korea Status and Prospect (2013-2025)
        1.4.5 Taiwan Status and Prospect (2013-2025)
        1.4.6 India Status and Prospect (2013-2025)
        1.4.7 Southeast Asia Status and Prospect (2013-2025)
        1.4.8 Australia Status and Prospect (2013-2025)
    1.5 Asia-Pacific Market Size (Value and Volume) of Spinal Muscular Atrophy Medicine (2013-2025)
        1.5.1 Asia-Pacific Spinal Muscular Atrophy Medicine Sales and Growth Rate (2013-2025)
        1.5.2 Asia-Pacific Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2013-2025)

2 Asia-Pacific Spinal Muscular Atrophy Medicine Competition by Players/Suppliers, Region, Type and Application
    2.1 Asia-Pacific Spinal Muscular Atrophy Medicine Market Competition by Players/Suppliers
        2.1.1 Asia-Pacific Spinal Muscular Atrophy Medicine Sales Volume and Market Share of Key Players/Suppliers (2013-2018)
        2.1.2 Asia-Pacific Spinal Muscular Atrophy Medicine Revenue and Share by Players/Suppliers (2013-2018)
    2.2 Asia-Pacific Spinal Muscular Atrophy Medicine (Volume and Value) by Type
        2.2.1 Asia-Pacific Spinal Muscular Atrophy Medicine Sales and Market Share by Type (2013-2018)
        2.2.2 Asia-Pacific Spinal Muscular Atrophy Medicine Revenue and Market Share by Type (2013-2018)
    2.3 Asia-Pacific Spinal Muscular Atrophy Medicine (Volume) by Application
    2.4 Asia-Pacific Spinal Muscular Atrophy Medicine (Volume and Value) by Region
        2.4.1 Asia-Pacific Spinal Muscular Atrophy Medicine Sales and Market Share by Region (2013-2018)
        2.4.2 Asia-Pacific Spinal Muscular Atrophy Medicine Revenue and Market Share by Region (2013-2018)

3 China Spinal Muscular Atrophy Medicine (Volume, Value and Sales Price)
    3.1 China Spinal Muscular Atrophy Medicine Sales and Value (2013-2018)
        3.1.1 China Spinal Muscular Atrophy Medicine Sales Volume and Growth Rate (2013-2018)
        3.1.2 China Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2013-2018)
        3.1.3 China Spinal Muscular Atrophy Medicine Sales Price Trend (2013-2018)
    3.2 China Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Type
    3.3 China Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Application

4 Japan Spinal Muscular Atrophy Medicine (Volume, Value and Sales Price)
    4.1 Japan Spinal Muscular Atrophy Medicine Sales and Value (2013-2018)
        4.1.1 Japan Spinal Muscular Atrophy Medicine Sales Volume and Growth Rate (2013-2018)
        4.1.2 Japan Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2013-2018)
        4.1.3 Japan Spinal Muscular Atrophy Medicine Sales Price Trend (2013-2018)
    4.2 Japan Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Type
    4.3 Japan Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Application

5 South Korea Spinal Muscular Atrophy Medicine (Volume, Value and Sales Price)
    5.1 South Korea Spinal Muscular Atrophy Medicine Sales and Value (2013-2018)
        5.1.1 South Korea Spinal Muscular Atrophy Medicine Sales Volume and Growth Rate (2013-2018)
        5.1.2 South Korea Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2013-2018)
        5.1.3 South Korea Spinal Muscular Atrophy Medicine Sales Price Trend (2013-2018)
    5.2 South Korea Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Type
    5.3 South Korea Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Application

6 Taiwan Spinal Muscular Atrophy Medicine (Volume, Value and Sales Price)
    6.1 Taiwan Spinal Muscular Atrophy Medicine Sales and Value (2013-2018)
        6.1.1 Taiwan Spinal Muscular Atrophy Medicine Sales Volume and Growth Rate (2013-2018)
        6.1.2 Taiwan Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2013-2018)
        6.1.3 Taiwan Spinal Muscular Atrophy Medicine Sales Price Trend (2013-2018)
    6.2 Taiwan Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Type
    6.3 Taiwan Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Application

7 India Spinal Muscular Atrophy Medicine (Volume, Value and Sales Price)
    7.1 India Spinal Muscular Atrophy Medicine Sales and Value (2013-2018)
        7.1.1 India Spinal Muscular Atrophy Medicine Sales Volume and Growth Rate (2013-2018)
        7.1.2 India Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2013-2018)
        7.1.3 India Spinal Muscular Atrophy Medicine Sales Price Trend (2013-2018)
    7.2 India Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Type
    7.3 India Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Application

8 Southeast Asia Spinal Muscular Atrophy Medicine (Volume, Value and Sales Price)
    8.1 Southeast Asia Spinal Muscular Atrophy Medicine Sales and Value (2013-2018)
        8.1.1 Southeast Asia Spinal Muscular Atrophy Medicine Sales Volume and Growth Rate (2013-2018)
        8.1.2 Southeast Asia Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2013-2018)
        8.1.3 Southeast Asia Spinal Muscular Atrophy Medicine Sales Price Trend (2013-2018)
    8.2 Southeast Asia Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Type
    8.3 Southeast Asia Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Application

9 Australia Spinal Muscular Atrophy Medicine (Volume, Value and Sales Price)
    9.1 Australia Spinal Muscular Atrophy Medicine Sales and Value (2013-2018)
        9.1.1 Australia Spinal Muscular Atrophy Medicine Sales Volume and Growth Rate (2013-2018)
        9.1.2 Australia Spinal Muscular Atrophy Medicine Revenue and Growth Rate (2013-2018)
        9.1.3 Australia Spinal Muscular Atrophy Medicine Sales Price Trend (2013-2018)
    9.2 Australia Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Type
    9.3 Australia Spinal Muscular Atrophy Medicine Sales Volume and Market Share by Application

10 Asia-Pacific Spinal Muscular Atrophy Medicine Players/Suppliers Profiles and Sales Data
    10.1 Astellas Pharma Inc.
        10.1.1 Company Basic Information, Manufacturing Base and Competitors
        10.1.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification
            10.1.2.1 Product A
            10.1.2.2 Product B
        10.1.3 Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
        10.1.4 Main Business/Business Overview
    10.2 AveXis, Inc.
        10.2.1 Company Basic Information, Manufacturing Base and Competitors
        10.2.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification
            10.2.2.1 Product A
            10.2.2.2 Product B
        10.2.3 AveXis, Inc. Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
        10.2.4 Main Business/Business Overview
    10.3 Bioblast Pharma Ltd.
        10.3.1 Company Basic Information, Manufacturing Base and Competitors
        10.3.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification
            10.3.2.1 Product A
            10.3.2.2 Product B
        10.3.3 Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
        10.3.4 Main Business/Business Overview
    10.4 Cytokinetics, Inc. 24
        10.4.1 Company Basic Information, Manufacturing Base and Competitors
        10.4.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification
            10.4.2.1 Product A
            10.4.2.2 Product B
        10.4.3 Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
        10.4.4 Main Business/Business Overview
    10.5 F. Hoffmann-La Roche Ltd.
        10.5.1 Company Basic Information, Manufacturing Base and Competitors
        10.5.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification
            10.5.2.1 Product A
            10.5.2.2 Product B
        10.5.3 F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
        10.5.4 Main Business/Business Overview
    10.6 Genethon
        10.6.1 Company Basic Information, Manufacturing Base and Competitors
        10.6.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification
            10.6.2.1 Product A
            10.6.2.2 Product B
        10.6.3 Genethon Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
        10.6.4 Main Business/Business Overview
    10.7 Genzyme Corporation
        10.7.1 Company Basic Information, Manufacturing Base and Competitors
        10.7.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification
            10.7.2.1 Product A
            10.7.2.2 Product B
        10.7.3 Genzyme Corporation Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
        10.7.4 Main Business/Business Overview
    10.8 GMP-Orphan SAS
        10.8.1 Company Basic Information, Manufacturing Base and Competitors
        10.8.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification
            10.8.2.1 Product A
            10.8.2.2 Product B
        10.8.3 GMP-Orphan SAS Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
        10.8.4 Main Business/Business Overview
    10.9 Ionis Pharmaceuticals, Inc.
        10.9.1 Company Basic Information, Manufacturing Base and Competitors
        10.9.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification
            10.9.2.1 Product A
            10.9.2.2 Product B
        10.9.3 Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
        10.9.4 Main Business/Business Overview
    10.10 Longevity Biotech, Inc
        10.10.1 Company Basic Information, Manufacturing Base and Competitors
        10.10.2 Spinal Muscular Atrophy Medicine Product Category, Application and Specification
            10.10.2.1 Product A
            10.10.2.2 Product B
        10.10.3 Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Sales, Revenue, Price and Gross Margin (2013-2018)
        10.10.4 Main Business/Business Overview
    10.11 Neurodyn Inc.
    10.12 Neurotune AG
    10.13 Novartis AG
    10.14 Sarepta Therapeutics, Inc.
    10.15 Voyager Therapeutics, Inc.
    10.16 Vybion, Inc.
    10.17 WAVE Life Sciences Ltd.

11 Spinal Muscular Atrophy Medicine Manufacturing Cost Analysis
    11.1 Spinal Muscular Atrophy Medicine Key Raw Materials Analysis
        11.1.1 Key Raw Materials
        11.1.2 Price Trend of Key Raw Materials
        11.1.3 Key Suppliers of Raw Materials
        11.1.4 Market Concentration Rate of Raw Materials
    11.2 Proportion of Manufacturing Cost Structure
        11.2.1 Raw Materials
        11.2.2 Labor Cost
        11.2.3 Manufacturing Expenses
    11.3 Manufacturing Process Analysis of Spinal Muscular Atrophy Medicine

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
    12.1 Spinal Muscular Atrophy Medicine Industrial Chain Analysis
    12.2 Upstream Raw Materials Sourcing
    12.3 Raw Materials Sources of Spinal Muscular Atrophy Medicine Major Manufacturers in 2017
    12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
    13.1 Marketing Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Development Trend
    13.2 Market Positioning
        13.2.1 Pricing Strategy
        13.2.2 Brand Strategy
        13.2.3 Target Client
    13.3 Distributors/Traders List

14 Market Effect Factors Analysis
    14.1 Technology Progress/Risk
        14.1.1 Substitutes Threat
        14.1.2 Technology Progress in Related Industry
    14.2 Consumer Needs/Customer Preference Change
    14.3 Economic/Political Environmental Change

15 Asia-Pacific Spinal Muscular Atrophy Medicine Market Forecast (2018-2025)
    15.1 Asia-Pacific Spinal Muscular Atrophy Medicine Sales Volume, Revenue and Price Forecast (2018-2025)
        15.1.1 Asia-Pacific Spinal Muscular Atrophy Medicine Sales Volume and Growth Rate Forecast (2018-2025)
        15.1.2 Asia-Pacific Spinal Muscular Atrophy Medicine Revenue and Growth Rate Forecast (2018-2025)
        15.1.3 Asia-Pacific Spinal Muscular Atrophy Medicine Price and Trend Forecast (2018-2025)
    15.2 Asia-Pacific Spinal Muscular Atrophy Medicine Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
        15.2.1 Asia-Pacific Spinal Muscular Atrophy Medicine Sales Volume and Growth Rate Forecast by Region (2018-2025)
        15.2.2 Asia-Pacific Spinal Muscular Atrophy Medicine Revenue and Growth Rate Forecast by Region (2018-2025)
        15.2.3 China Spinal Muscular Atrophy Medicine Sales, Revenue and Growth Rate Forecast (2018-2025)
        15.2.4 Japan Spinal Muscular Atrophy Medicine Sales, Revenue and Growth Rate Forecast (2018-2025)
        15.2.5 South Korea Spinal Muscular Atrophy Medicine Sales, Revenue and Growth Rate Forecast (2018-2025)
        15.2.6 Taiwan Spinal Muscular Atrophy Medicine Sales, Revenue and Growth Rate Forecast (2018-2025)
        15.2.7 India Spinal Muscular Atrophy Medicine Sales, Revenue and Growth Rate Forecast (2018-2025)
        15.2.8 Southeast Asia Spinal Muscular Atrophy Medicine Sales, Revenue and Growth Rate Forecast (2018-2025)
        15.2.9 Australia Spinal Muscular Atrophy Medicine Sales, Revenue and Growth Rate Forecast (2018-2025)
    15.3 Asia-Pacific Spinal Muscular Atrophy Medicine Sales, Revenue and Price Forecast by Type (2018-2025)
        15.3.1 Asia-Pacific Spinal Muscular Atrophy Medicine Sales Forecast by Type (2018-2025)
        15.3.2 Asia-Pacific Spinal Muscular Atrophy Medicine Revenue Forecast by Type (2018-2025)
        15.3.3 Asia-Pacific Spinal Muscular Atrophy Medicine Price Forecast by Type (2018-2025)
    15.4 Asia-Pacific Spinal Muscular Atrophy Medicine Sales Forecast by Application (2018-2025)

16 Research Findings and Conclusion

17 Appendix
    17.1 Methodology/Research Approach
        17.1.1 Research Programs/Design
        17.1.2 Market Size Estimation
        17.1.3 Market Breakdown and Data Triangulation
    17.2 Data Source
        17.2.1 Secondary Sources
        17.2.2 Primary Sources
    17.3 Disclaimer


List of Tables and Figures

    Figure Product Picture of Spinal Muscular Atrophy Medicine
    Figure Asia-Pacific Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Type (2013-2025)
    Figure Asia-Pacific Spinal Muscular Atrophy Medicine Sales Volume Market Share by Type (Product Category) in 2017
    Figure LMI-070 Product Picture
    Figure ND-602 Product Picture
    Figure NT-1654 Product Picture
    Figure Nusinersen Product Picture
    Figure NXD-30001 Product Picture
    Figure Others Product Picture
    Figure Asia-Pacific Spinal Muscular Atrophy Medicine Sales (K Pcs) by Application (2013-2025)
    Figure Asia-Pacific Sales Market Share of Spinal Muscular Atrophy Medicine by Application in 2017
    Figure Hospital Examples
    Table Key Downstream Customer in Hospital
    Figure Clinic Examples
    Table Key Downstream Customer in Clinic
    Figure Others Examples
    Table Key Downstream Customer in Others
    Figure Asia-Pacific Spinal Muscular Atrophy Medicine Market Size (Million USD) by Region (2013-2025)
    Figure China Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Japan Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2025)
    Figure South Korea Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Taiwan Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2025)
    Figure India Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Southeast Asia Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Australia Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Asia-Pacific Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) and Growth Rate (2013-2025)
    Figure Asia-Pacific Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2025)
    Figure Asia-Pacific Spinal Muscular Atrophy Medicine Market Major Players Product Sales Volume (K Pcs)(2013-2018)
    Table Asia-Pacific Spinal Muscular Atrophy Medicine Sales (K Pcs) of Key Players/Suppliers (2013-2018)
    Table Asia-Pacific Spinal Muscular Atrophy Medicine Sales Share by Players/Suppliers (2013-2018)
    Figure 2017 Asia-Pacific Spinal Muscular Atrophy Medicine Sales Share by Players/Suppliers
    Figure 2017 Asia-Pacific Spinal Muscular Atrophy Medicine Sales Share by Players/Suppliers
    Figure Asia-Pacific Spinal Muscular Atrophy Medicine Market Major Players Product Revenue (Million USD) 2013-2018
    Table Asia-Pacific Spinal Muscular Atrophy Medicine Revenue (Million USD) by Players/Suppliers (2013-2018)
    Table Asia-Pacific Spinal Muscular Atrophy Medicine Revenue Share by Players/Suppliers (2013-2018)
    Figure 2017 Asia-Pacific Spinal Muscular Atrophy Medicine Revenue Share by Players
    Figure 2017 Asia-Pacific Spinal Muscular Atrophy Medicine Revenue Share by Players
    Table Asia-Pacific Spinal Muscular Atrophy Medicine Sales and Market Share by Type (2013-2018)
    Table Asia-Pacific Spinal Muscular Atrophy Medicine Sales Share by Type (2013-2018)
    Figure Sales Market Share of Spinal Muscular Atrophy Medicine by Type (2013-2018)
    Figure Asia-Pacific Spinal Muscular Atrophy Medicine Sales Growth Rate by Type (2013-2018)
    Table Asia-Pacific Spinal Muscular Atrophy Medicine Revenue (Million USD) and Market Share by Type (2013-2018)
    Table Asia-Pacific Spinal Muscular Atrophy Medicine Revenue Share by Type (2013-2018)
    Figure Revenue Market Share of Spinal Muscular Atrophy Medicine by Type (2013-2018)
    Figure Asia-Pacific Spinal Muscular Atrophy Medicine Revenue Growth Rate by Type (2013-2018)
    Table Asia-Pacific Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) and Market Share by Region (2013-2018)
    Table Asia-Pacific Spinal Muscular Atrophy Medicine Sales Share by Region (2013-2018)
    Figure Sales Market Share of Spinal Muscular Atrophy Medicine by Region (2013-2018)
    Figure Asia-Pacific Spinal Muscular Atrophy Medicine Sales Market Share by Region in 2017
    Table Asia-Pacific Spinal Muscular Atrophy Medicine Revenue (Million USD) and Market Share by Region (2013-2018)
    Table Asia-Pacific Spinal Muscular Atrophy Medicine Revenue Share (%) by Region (2013-2018)
    Figure Revenue Market Share of Spinal Muscular Atrophy Medicine by Region (2013-2018)
    Figure Asia-Pacific Spinal Muscular Atrophy Medicine Revenue Market Share by Region in 2017
    Table Asia-Pacific Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) and Market Share by Application (2013-2018)
    Table Asia-Pacific Spinal Muscular Atrophy Medicine Sales Share (%) by Application (2013-2018)
    Figure Asia-Pacific Spinal Muscular Atrophy Medicine Sales Market Share by Application (2013-2018)
    Figure Asia-Pacific Spinal Muscular Atrophy Medicine Sales Market Share by Application (2013-2018)
    Figure China Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate (2013-2018)
    Figure China Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2018)
    Figure China Spinal Muscular Atrophy Medicine Sales Price (USD/Pcs) Trend (2013-2018)
    Table China Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Type (2013-2018)
    Table China Spinal Muscular Atrophy Medicine Sales Volume Market Share by Type (2013-2018)
    Figure China Spinal Muscular Atrophy Medicine Sales Volume Market Share by Type in 2017
    Table China Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Applications (2013-2018)
    Table China Spinal Muscular Atrophy Medicine Sales Volume Market Share by Application (2013-2018)
    Figure China Spinal Muscular Atrophy Medicine Sales Volume Market Share by Application in 2017
    Figure Japan Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate (2013-2018)
    Figure Japan Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2018)
    Figure Japan Spinal Muscular Atrophy Medicine Sales Price (USD/Pcs) Trend (2013-2018)
    Table Japan Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Type (2013-2018)
    Table Japan Spinal Muscular Atrophy Medicine Sales Volume Market Share by Type (2013-2018)
    Figure Japan Spinal Muscular Atrophy Medicine Sales Volume Market Share by Type in 2017
    Table Japan Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Applications (2013-2018)
    Table Japan Spinal Muscular Atrophy Medicine Sales Volume Market Share by Application (2013-2018)
    Figure Japan Spinal Muscular Atrophy Medicine Sales Volume Market Share by Application in 2017
    Figure South Korea Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate (2013-2018)
    Figure South Korea Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2018)
    Figure South Korea Spinal Muscular Atrophy Medicine Sales Price (USD/Pcs) Trend (2013-2018)
    Table South Korea Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Type (2013-2018)
    Table South Korea Spinal Muscular Atrophy Medicine Sales Volume Market Share by Type (2013-2018)
    Figure South Korea Spinal Muscular Atrophy Medicine Sales Volume Market Share by Type in 2017
    Table South Korea Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Applications (2013-2018)
    Table South Korea Spinal Muscular Atrophy Medicine Sales Volume Market Share by Application (2013-2018)
    Figure South Korea Spinal Muscular Atrophy Medicine Sales Volume Market Share by Application in 2017
    Figure Taiwan Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate (2013-2018)
    Figure Taiwan Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2018)
    Figure Taiwan Spinal Muscular Atrophy Medicine Sales Price (USD/Pcs) Trend (2013-2018)
    Table Taiwan Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Type (2013-2018)
    Table Taiwan Spinal Muscular Atrophy Medicine Sales Volume Market Share by Type (2013-2018)
    Figure Taiwan Spinal Muscular Atrophy Medicine Sales Volume Market Share by Type in 2017
    Table Taiwan Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Applications (2013-2018)
    Table Taiwan Spinal Muscular Atrophy Medicine Sales Volume Market Share by Application (2013-2018)
    Figure Taiwan Spinal Muscular Atrophy Medicine Sales Volume Market Share by Application in 2017
    Figure India Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate (2013-2018)
    Figure India Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2018)
    Figure India Spinal Muscular Atrophy Medicine Sales Price (USD/Pcs) Trend (2013-2018)
    Table India Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Type (2013-2018)
    Table India Spinal Muscular Atrophy Medicine Sales Volume Market Share by Type (2013-2018)
    Figure India Spinal Muscular Atrophy Medicine Sales Volume Market Share by Type in 2017
    Table India Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Application (2013-2018)
    Table India Spinal Muscular Atrophy Medicine Sales Volume Market Share by Application (2013-2018)
    Figure India Spinal Muscular Atrophy Medicine Sales Volume Market Share by Application in 2017
    Figure Southeast Asia Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate (2013-2018)
    Figure Southeast Asia Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2018)
    Figure Southeast Asia Spinal Muscular Atrophy Medicine Sales Price (USD/Pcs) Trend (2013-2018)
    Table Southeast Asia Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Type (2013-2018)
    Table Southeast Asia Spinal Muscular Atrophy Medicine Sales Volume Market Share by Type (2013-2018)
    Figure Southeast Asia Spinal Muscular Atrophy Medicine Sales Volume Market Share by Type in 2017
    Table Southeast Asia Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Applications (2013-2018)
    Table Southeast Asia Spinal Muscular Atrophy Medicine Sales Volume Market Share by Application (2013-2018)
    Figure Southeast Asia Spinal Muscular Atrophy Medicine Sales Volume Market Share by Application in 2017
    Figure Australia Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate (2013-2018)
    Figure Australia Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate (2013-2018)
    Figure Australia Spinal Muscular Atrophy Medicine Sales Price (USD/Pcs) Trend (2013-2018)
    Table Australia Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Type (2013-2018)
    Table Australia Spinal Muscular Atrophy Medicine Sales Volume Market Share by Type (2013-2018)
    Figure Australia Spinal Muscular Atrophy Medicine Sales Volume Market Share by Type in 2017
    Table Australia Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) by Applications (2013-2018)
    Table Australia Spinal Muscular Atrophy Medicine Sales Volume Market Share by Application (2013-2018)
    Figure Australia Spinal Muscular Atrophy Medicine Sales Volume Market Share by Application in 2017
    Table Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Basic Information List
    Table Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
    Figure Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate (2013-2018)
    Figure Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Sales Market Share in Asia-Pacific (2013-2018)
    Figure Astellas Pharma Inc. Spinal Muscular Atrophy Medicine Revenue Market Share in Asia-Pacific (2013-2018)
    Table AveXis, Inc. Spinal Muscular Atrophy Medicine Basic Information List
    Table AveXis, Inc. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
    Figure AveXis, Inc. Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate (2013-2018)
    Figure AveXis, Inc. Spinal Muscular Atrophy Medicine Sales Market Share in Asia-Pacific (2013-2018)
    Figure AveXis, Inc. Spinal Muscular Atrophy Medicine Revenue Market Share in Asia-Pacific (2013-2018)
    Table Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Basic Information List
    Table Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
    Figure Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate (2013-2018)
    Figure Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Sales Market Share in Asia-Pacific (2013-2018)
    Figure Bioblast Pharma Ltd. Spinal Muscular Atrophy Medicine Revenue Market Share in Asia-Pacific (2013-2018)
    Table Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Basic Information List
    Table Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
    Figure Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate (2013-2018)
    Figure Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Sales Market Share in Asia-Pacific (2013-2018)
    Figure Cytokinetics, Inc. 24 Spinal Muscular Atrophy Medicine Revenue Market Share in Asia-Pacific (2013-2018)
    Table F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Basic Information List
    Table F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
    Figure F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate (2013-2018)
    Figure F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Sales Market Share in Asia-Pacific (2013-2018)
    Figure F. Hoffmann-La Roche Ltd. Spinal Muscular Atrophy Medicine Revenue Market Share in Asia-Pacific (2013-2018)
    Table Genethon Spinal Muscular Atrophy Medicine Basic Information List
    Table Genethon Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
    Figure Genethon Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate (2013-2018)
    Figure Genethon Spinal Muscular Atrophy Medicine Sales Market Share in Asia-Pacific (2013-2018)
    Figure Genethon Spinal Muscular Atrophy Medicine Revenue Market Share in Asia-Pacific (2013-2018)
    Table Genzyme Corporation Spinal Muscular Atrophy Medicine Basic Information List
    Table Genzyme Corporation Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
    Figure Genzyme Corporation Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate (2013-2018)
    Figure Genzyme Corporation Spinal Muscular Atrophy Medicine Sales Market Share in Asia-Pacific (2013-2018)
    Figure Genzyme Corporation Spinal Muscular Atrophy Medicine Revenue Market Share in Asia-Pacific (2013-2018)
    Table GMP-Orphan SAS Spinal Muscular Atrophy Medicine Basic Information List
    Table GMP-Orphan SAS Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
    Figure GMP-Orphan SAS Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate (2013-2018)
    Figure GMP-Orphan SAS Spinal Muscular Atrophy Medicine Sales Market Share in Asia-Pacific (2013-2018)
    Figure GMP-Orphan SAS Spinal Muscular Atrophy Medicine Revenue Market Share in Asia-Pacific (2013-2018)
    Table Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Basic Information List
    Table Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
    Figure Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate (2013-2018)
    Figure Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Sales Market Share in Asia-Pacific (2013-2018)
    Figure Ionis Pharmaceuticals, Inc. Spinal Muscular Atrophy Medicine Revenue Market Share in Asia-Pacific (2013-2018)
    Table Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Basic Information List
    Table Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
    Figure Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate (2013-2018)
    Figure Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Sales Market Share in Asia-Pacific (2013-2018)
    Figure Longevity Biotech, Inc Spinal Muscular Atrophy Medicine Revenue Market Share in Asia-Pacific (2013-2018)
    Table Neurodyn Inc. Spinal Muscular Atrophy Medicine Basic Information List
    Table Neurotune AG Spinal Muscular Atrophy Medicine Basic Information List
    Table Novartis AG Spinal Muscular Atrophy Medicine Basic Information List
    Table Sarepta Therapeutics, Inc. Spinal Muscular Atrophy Medicine Basic Information List
    Table Voyager Therapeutics, Inc. Spinal Muscular Atrophy Medicine Basic Information List
    Table Vybion, Inc. Spinal Muscular Atrophy Medicine Basic Information List
    Table WAVE Life Sciences Ltd. Spinal Muscular Atrophy Medicine Basic Information List
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price (USD/Pcs) Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of Spinal Muscular Atrophy Medicine
    Figure Manufacturing Process Analysis of Spinal Muscular Atrophy Medicine
    Figure Spinal Muscular Atrophy Medicine Industrial Chain Analysis
    Table Raw Materials Sources of Spinal Muscular Atrophy Medicine Major Manufacturers in 2017
    Table Major Buyers of Spinal Muscular Atrophy Medicine
    Table Distributors/Traders List
    Figure Asia-Pacific Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
    Figure Asia-Pacific Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Figure Asia-Pacific Spinal Muscular Atrophy Medicine Price (USD/Pcs) and Trend Forecast (2018-2025)
    Table Asia-Pacific Spinal Muscular Atrophy Medicine Sales Volume (K Pcs) Forecast by Region (2018-2025)
    Figure Asia-Pacific Spinal Muscular Atrophy Medicine Sales Volume Market Share Forecast by Region (2018-2025)
    Figure Asia-Pacific Spinal Muscular Atrophy Medicine Sales Volume Market Share Forecast by Region in 2025
    Table Asia-Pacific Spinal Muscular Atrophy Medicine Revenue (Million USD) Forecast by Region (2018-2025)
    Figure Asia-Pacific Spinal Muscular Atrophy Medicine Revenue Market Share Forecast by Region (2018-2025)
    Figure Asia-Pacific Spinal Muscular Atrophy Medicine Revenue Market Share Forecast by Region in 2025
    Figure China Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate Forecast (2018-2025)
    Figure China Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Figure Japan Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate Forecast (2018-2025)
    Figure Japan Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Figure South Korea Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate Forecast (2018-2025)
    Figure South Korea Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Figure Taiwan Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate Forecast (2018-2025)
    Figure Taiwan Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Figure India Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate Forecast (2018-2025)
    Figure India Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Figure Southeast Asia Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate Forecast (2018-2025)
    Figure Southeast Asia Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Figure Australia Spinal Muscular Atrophy Medicine Sales (K Pcs) and Growth Rate Forecast (2018-2025)
    Figure Australia Spinal Muscular Atrophy Medicine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
    Table Asia-Pacific Spinal Muscular Atrophy Medicine Sales (K Pcs) Forecast by Type (2018-2025)
    Figure Asia-Pacific Spinal Muscular Atrophy Medicine Sales Market Share Forecast by Type (2018-2025)
    Table Asia-Pacific Spinal Muscular Atrophy Medicine Revenue (Million USD) Forecast by Type (2018-2025)
    Figure Asia-Pacific Spinal Muscular Atrophy Medicine Revenue Market Share Forecast by Type (2018-2025)
    Table Asia-Pacific Spinal Muscular Atrophy Medicine Price (USD/Pcs) Forecast by Type (2018-2025)
    Table Asia-Pacific Spinal Muscular Atrophy Medicine Sales (K Pcs) Forecast by Application (2018-2025)
    Figure Asia-Pacific Spinal Muscular Atrophy Medicine Sales Market Share Forecast by Application (2018-2025)
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources
 



To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $4000
Multi User - US $8000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify